Clinical trial
The Effect of Neoadjuvant Chemotherapy on Lactate Threshold in Patients With Surgically Resectable Upper Gastrointestinal Cancer.
NCT01335555 is registered in ClinicalTrials.gov with Liverpool University Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Neoadjuvant Chemotherapy on Lactate Threshold in Patients With Surgically Resectable Upper Gastrointestinal Cancer.
- Lead sponsor
- Liverpool University Hospitals NHS Foundation Trust
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- August 31, 2009
- Enrollment
- 89 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, effects of chemotherapy